Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant live-attenuated influenza H2N2 vaccine

recombinant live-attenuated influenza H2N2 vaccine · National Institute of Allergy and Infectious Diseases
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant live-attenuated influenza H2N2 vaccine, covering 2008-11-10 to 2008-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine [Phase 1]

See pricing